Ticker Details
Fulgent Genetics, Inc. Fulgent Genetics Inc is a technology company offering genetic testing to provide physicians with clinically actionable diagnostic information used to improve the overall quality of patient care.
IPO Date:	September 29, 2016
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$433.25M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.88 | 2.84%
Avg Daily Range (30 D):	$0.46 | 2.85%
Avg Daily Range (90 D):	$0.35 | 1.71%

Institutional Daily Volume
Avg Daily Volume:	.3M
Avg Daily Volume (30 D):	.69M
Avg Daily Volume (90 D):	.33M

Trade Size
Avg Trade Size (Sh.):	62
Avg Trade Size (Sh.) (30 D):	55
Avg Trade Size (Sh.) (90 D):	47

Institutional Trades
Total Institutional Trades:	1,903
Avg Institutional Trade:	$1.77M
Avg Institutional Trade (30 D):	$1.45M
Avg Institutional Trade (90 D):	$1.18M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.86M
Avg Closing Trade (30 D):	$1.39M
Avg Closing Trade (90 D):	$1.15M
Avg Closing Volume:	45.37K

News

Mar 20, 2026 @ 12:00 AM FLGT SHAREHOLDER ALERT: Investors Encouraged to Co... Source: Kirby Mcinerney Llp

Jan 30, 2026 @ 9:57 AM Esoteric Testing Research Report 2026 - Global $41... Source: Researchandmarkets.Com

Aug 1, 2025 @ 8:26 PM Why Fulgent Genetics Stock Was Crushing It on Frid... Source: Eric Volkman

Jul 15, 2025 @ 11:41 PM Bragar Eagel & Squire, P.C. Is Investigating GoHea... Source: Bragar Eagel & Squire, P.C.

Jul 1, 2025 @ 1:00 AM Bragar Eagel & Squire, P.C. Is Investigating GoHea... Source: Bragar Eagel & Squire, P.C.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS
Diluted EPS
Revenue	$322.67M	$83.34M	$322.67M
Gross Profit	$130.88M	$32.58M	$130.88M
Net Income / Loss	$-61.63M	$-23.65M	$-61.63M
Operating Income / Loss	$-91.1M	$-36.24M	$-91.1M
Cost of Revenue	$191.8M	$50.75M	$191.8M
Net Cash Flow	$-4.95M	$-67.45M	$-4.95M
PE Ratio